Read more about the article Pharvaris Reports Promising Durability Data for Deucrictibant in Treating Hereditary Angioedema and Highlights Potential for Expanded Use in Bradykinin-Mediated Angioedema
Pharvaris Reports Promising Durability Data for Deucrictibant in Treating Hereditary Angioedema and Highlights Potential for Expanded Use in Bradykinin-Mediated Angioedema

Pharvaris Reports Promising Durability Data for Deucrictibant in Treating Hereditary Angioedema and Highlights Potential for Expanded Use in Bradykinin-Mediated Angioedema

Pharvaris announces positive deucrictibant data indicating safety and efficacy for hereditary angioedema treatment and potential expansion.Quiver AI SummaryPharvaris has announced promising data regarding deucrictibant, a novel oral bradykinin B2 receptor…

Continue ReadingPharvaris Reports Promising Durability Data for Deucrictibant in Treating Hereditary Angioedema and Highlights Potential for Expanded Use in Bradykinin-Mediated Angioedema
Read more about the article Castellum, Inc. CEO Glen Ives to Present at 2025 Virtual Tech Conference Hosted by Maxim Group LLC
Castellum, Inc. CEO Glen Ives to Present at 2025 Virtual Tech Conference Hosted by Maxim Group LLC

Castellum, Inc. CEO Glen Ives to Present at 2025 Virtual Tech Conference Hosted by Maxim Group LLC

Castellum, Inc. CEO Glen Ives will present at the 2025 Virtual Tech Conference from June 3rd to 5th.Quiver AI SummaryCastellum, Inc. announced that CEO Glen Ives will present at the…

Continue ReadingCastellum, Inc. CEO Glen Ives to Present at 2025 Virtual Tech Conference Hosted by Maxim Group LLC
Read more about the article Brazil Potash Corp. Reports Significant Progress and Strategic Achievements Ahead of Wells Fargo Industrials Conference
Brazil Potash Corp. Reports Significant Progress and Strategic Achievements Ahead of Wells Fargo Industrials Conference

Brazil Potash Corp. Reports Significant Progress and Strategic Achievements Ahead of Wells Fargo Industrials Conference

Brazil Potash reports key achievements in governance, construction, and financing for its Autazes Potash Project ahead of June conference.Quiver AI SummaryBrazil Potash Corp. has made significant progress in 2025 toward…

Continue ReadingBrazil Potash Corp. Reports Significant Progress and Strategic Achievements Ahead of Wells Fargo Industrials Conference
Read more about the article BioNTech and Bristol Myers Squibb Announce Global Co-Development of BNT327, a Novel Bispecific Antibody for Solid Tumors
BioNTech and Bristol Myers Squibb Announce Global Co-Development of BNT327, a Novel Bispecific Antibody for Solid Tumors

BioNTech and Bristol Myers Squibb Announce Global Co-Development of BNT327, a Novel Bispecific Antibody for Solid Tumors

BioNTech and Bristol Myers Squibb announced a collaboration to co-develop the bispecific antibody BNT327 for solid tumors.Quiver AI SummaryBioNTech and Bristol Myers Squibb have announced a partnership for the global…

Continue ReadingBioNTech and Bristol Myers Squibb Announce Global Co-Development of BNT327, a Novel Bispecific Antibody for Solid Tumors
Read more about the article Codere Online Luxembourg, S.A. Files Annual 20-F Report, Regaining Nasdaq Compliance
Codere Online Luxembourg, S.A. Files Annual 20-F Report, Regaining Nasdaq Compliance

Codere Online Luxembourg, S.A. Files Annual 20-F Report, Regaining Nasdaq Compliance

Codere Online Luxembourg filed its 2024 annual report, regaining compliance with Nasdaq rules, pending final confirmation.Quiver AI SummaryCodere Online Luxembourg, S.A., a prominent online gaming operator in Spain and Latin…

Continue ReadingCodere Online Luxembourg, S.A. Files Annual 20-F Report, Regaining Nasdaq Compliance
Read more about the article Hyperscale Data, Inc. Sells Minority Stake in Pharmaceutical Company for $4.65 Million, Focuses on Michigan Data Center Development
Hyperscale Data, Inc. Sells Minority Stake in Pharmaceutical Company for $4.65 Million, Focuses on Michigan Data Center Development

Hyperscale Data, Inc. Sells Minority Stake in Pharmaceutical Company for $4.65 Million, Focuses on Michigan Data Center Development

Hyperscale Data sells minority interest in a pharmaceutical company for $4.65 million, focusing on data center expansion in Michigan.Quiver AI SummaryHyperscale Data, Inc. announced the sale of its minority equity…

Continue ReadingHyperscale Data, Inc. Sells Minority Stake in Pharmaceutical Company for $4.65 Million, Focuses on Michigan Data Center Development
Read more about the article Vera Therapeutics Reports Positive Results from ORIGIN Phase 3 Trial of Atacicept for IgA Nephropathy, Meeting Primary Endpoint
Vera Therapeutics Reports Positive Results from ORIGIN Phase 3 Trial of Atacicept for IgA Nephropathy, Meeting Primary Endpoint

Vera Therapeutics Reports Positive Results from ORIGIN Phase 3 Trial of Atacicept for IgA Nephropathy, Meeting Primary Endpoint

Atacicept met its primary endpoint in the ORIGIN Phase 3 trial, significantly reducing proteinuria in IgAN patients.Quiver AI SummaryVera Therapeutics, Inc. announced that its ORIGIN Phase 3 trial for atacicept,…

Continue ReadingVera Therapeutics Reports Positive Results from ORIGIN Phase 3 Trial of Atacicept for IgA Nephropathy, Meeting Primary Endpoint
Read more about the article Liquidia Corporation Announces Commercial Launch of YUTREPIA for Treatment of Pulmonary Arterial Hypertension Following FDA Approval and Legal Ruling
Liquidia Corporation Announces Commercial Launch of YUTREPIA for Treatment of Pulmonary Arterial Hypertension Following FDA Approval and Legal Ruling

Liquidia Corporation Announces Commercial Launch of YUTREPIA for Treatment of Pulmonary Arterial Hypertension Following FDA Approval and Legal Ruling

Liquidia announces FDA approval and commercial launch of YUTREPIA for treating pulmonary arterial hypertension and PH-ILD.Quiver AI SummaryLiquidia Corporation has announced that its inhalation powder YUTREPIA™ (treprostinil) is now available…

Continue ReadingLiquidia Corporation Announces Commercial Launch of YUTREPIA for Treatment of Pulmonary Arterial Hypertension Following FDA Approval and Legal Ruling
Read more about the article Piedmont Office Realty Trust Announces Participation in Nareit REITWeek and Increases 2025 Leasing Guidance
Piedmont Office Realty Trust Announces Participation in Nareit REITWeek and Increases 2025 Leasing Guidance

Piedmont Office Realty Trust Announces Participation in Nareit REITWeek and Increases 2025 Leasing Guidance

Piedmont Office Realty Trust announces significant second quarter leasing success and participation in Nareit REITWeek Investor Conference in NYC.Quiver AI SummaryPiedmont Office Realty Trust, Inc. announced its participation in the…

Continue ReadingPiedmont Office Realty Trust Announces Participation in Nareit REITWeek and Increases 2025 Leasing Guidance

End of content

No more pages to load

Newer Posts
Older Posts